The Cancer and Stem Cells Institute Jakarta
The Stem Cell and Cancer Institute (SCI) is an institute established in Jakarta, Indonesia on December 1, 2006 by Kalbe Pharmaceutical Company, one of the largest pharmaceutical companies in South East Asia.
Boenjamin Setiawan, M.D., Ph.D., the Chairman of Kalbe Pharmaceutical Company, together with Ferry Sandra, Ph.D. initiated the establishment of Stem Cell and Cancer Institute.
|
Organisationally, SCI will be overseen by Kalbe Pharmaceutical
Company and operates side by side with the Kalbe Corporate R&D and
Innogene Kalbiotech. However, SCI is an independent institution with
full authority to operate or stand on its own projects and
administration. SCI has a truthful goal for the benefit of promotion in
Indonesian research with the specific scope: to conduct researches in
stem cell and cancer, which later can be useful for the humanity in
promoting the health and life quality.
|
|